NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDRisankizumab Skyrizi®
(600mg concentrate for solution for infusion, 360mg solution for injection in cartridge) 		Gastro-intestinal system, Cytokine inhibitors, 01.05.03
REDRisankizumab Skyrizi®
(150mg solution for injection in pre-filled syringe or pen) 		Musculoskeletal and joint diseases, Cytokine modulators, 10.01.03
REDRisankizumab Skyrizi®
(150mg solution for injection in pre-filled syringe or pen) 		Skin, Drugs affecting the immune response, 13.05.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Risankizumab Risankizumab Gastro-Intestinal System, Chronic Bowel Disorders, Inflammatory Bowel Disease, Immunosuppressants Interleukin Inhibitors
Risankizumab Risankizumab Musculoskeletal System, Arthritis, Immunosuppressants Interleukin Inhibitors
Risankizumab Risankizumab Skin, Inflammatory Skin Conditions, Eczema And Psoriasis, Immunosuppressants Interleukin Inhibitors
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA596 Risankizumab for treating moderate to severe plaque psoriasis
NICE TA803 Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs
NICE TA803: Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs
NICE TA888: Risankizumab for previously treated moderately to severely active Crohn’s disease
NICE TA998: Risankizumab for treating moderately to severely active ulcerative colitis